nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.00757	0.286	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.00398	0.15	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.00228	0.0864	CbGpPWpGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.00224	0.0847	CbGpPWpGaD
Travoprost—Tafluprost—PTGS2—kidney cancer	0.00133	1	CrCbGaD
Travoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.000875	0.0331	CbGpPWpGaD
Travoprost—Mental disorder—Paclitaxel—kidney cancer	0.000696	0.000716	CcSEcCtD
Travoprost—Discomfort—Gemcitabine—kidney cancer	0.000695	0.000715	CcSEcCtD
Travoprost—Erythema—Paclitaxel—kidney cancer	0.000692	0.000712	CcSEcCtD
Travoprost—Diarrhoea—Vinblastine—kidney cancer	0.000691	0.000711	CcSEcCtD
Travoprost—Abdominal pain—Sorafenib—kidney cancer	0.000691	0.00071	CcSEcCtD
Travoprost—Diarrhoea—Everolimus—kidney cancer	0.000689	0.000708	CcSEcCtD
Travoprost—Gastrointestinal pain—Sunitinib—kidney cancer	0.000687	0.000707	CcSEcCtD
Travoprost—Pruritus—Erlotinib—kidney cancer	0.000687	0.000707	CcSEcCtD
Travoprost—Fatigue—Dactinomycin—kidney cancer	0.000686	0.000706	CcSEcCtD
Travoprost—Pain—Dactinomycin—kidney cancer	0.000681	0.0007	CcSEcCtD
Travoprost—Dysgeusia—Paclitaxel—kidney cancer	0.000678	0.000697	CcSEcCtD
Travoprost—Oedema—Gemcitabine—kidney cancer	0.000674	0.000694	CcSEcCtD
Travoprost—Eye pain—Doxorubicin—kidney cancer	0.000673	0.000692	CcSEcCtD
Travoprost—Infection—Gemcitabine—kidney cancer	0.00067	0.000689	CcSEcCtD
Travoprost—Back pain—Paclitaxel—kidney cancer	0.000669	0.000688	CcSEcCtD
Travoprost—Dizziness—Vinblastine—kidney cancer	0.000668	0.000687	CcSEcCtD
Travoprost—Dizziness—Everolimus—kidney cancer	0.000666	0.000685	CcSEcCtD
Travoprost—Abdominal pain—Sunitinib—kidney cancer	0.000665	0.000684	CcSEcCtD
Travoprost—Diarrhoea—Erlotinib—kidney cancer	0.000664	0.000683	CcSEcCtD
Travoprost—Hypotension—Vincristine—kidney cancer	0.000664	0.000683	CcSEcCtD
Travoprost—Bradycardia—Capecitabine—kidney cancer	0.000664	0.000683	CcSEcCtD
Travoprost—Nervous system disorder—Gemcitabine—kidney cancer	0.000661	0.00068	CcSEcCtD
Travoprost—Feeling abnormal—Dactinomycin—kidney cancer	0.000656	0.000675	CcSEcCtD
Travoprost—Skin disorder—Gemcitabine—kidney cancer	0.000655	0.000674	CcSEcCtD
Travoprost—Rhinitis—Capecitabine—kidney cancer	0.000654	0.000673	CcSEcCtD
Travoprost—Vision blurred—Paclitaxel—kidney cancer	0.000652	0.000671	CcSEcCtD
Travoprost—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000651	0.000669	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000648	0.000666	CcSEcCtD
Travoprost—Pharyngitis—Capecitabine—kidney cancer	0.000647	0.000666	CcSEcCtD
Travoprost—Urinary tract disorder—Capecitabine—kidney cancer	0.000644	0.000663	CcSEcCtD
Travoprost—Hypersensitivity—Sorafenib—kidney cancer	0.000644	0.000662	CcSEcCtD
Travoprost—Dizziness—Erlotinib—kidney cancer	0.000642	0.00066	CcSEcCtD
Travoprost—Ill-defined disorder—Paclitaxel—kidney cancer	0.000642	0.00066	CcSEcCtD
Travoprost—Connective tissue disorder—Capecitabine—kidney cancer	0.000641	0.000659	CcSEcCtD
Travoprost—Urethral disorder—Capecitabine—kidney cancer	0.000639	0.000658	CcSEcCtD
Travoprost—Rash—Everolimus—kidney cancer	0.000635	0.000653	CcSEcCtD
Travoprost—Dermatitis—Everolimus—kidney cancer	0.000634	0.000652	CcSEcCtD
Travoprost—Headache—Vinblastine—kidney cancer	0.000633	0.000651	CcSEcCtD
Travoprost—Headache—Everolimus—kidney cancer	0.00063	0.000648	CcSEcCtD
Travoprost—Hypotension—Gemcitabine—kidney cancer	0.00063	0.000648	CcSEcCtD
Travoprost—Abdominal pain—Dactinomycin—kidney cancer	0.000629	0.000647	CcSEcCtD
Travoprost—Visual impairment—Capecitabine—kidney cancer	0.000629	0.000647	CcSEcCtD
Travoprost—Asthenia—Sorafenib—kidney cancer	0.000627	0.000645	CcSEcCtD
Travoprost—Malaise—Paclitaxel—kidney cancer	0.000624	0.000642	CcSEcCtD
Travoprost—Vertigo—Paclitaxel—kidney cancer	0.000622	0.000639	CcSEcCtD
Travoprost—Hypersensitivity—Sunitinib—kidney cancer	0.000619	0.000637	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—ITPR2—kidney cancer	0.000618	0.0234	CbGpPWpGaD
Travoprost—Pruritus—Sorafenib—kidney cancer	0.000618	0.000636	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000615	0.000632	CcSEcCtD
Travoprost—Gastrointestinal disorder—Vincristine—kidney cancer	0.000614	0.000631	CcSEcCtD
Travoprost—Fatigue—Vincristine—kidney cancer	0.000613	0.000631	CcSEcCtD
Travoprost—Rash—Erlotinib—kidney cancer	0.000612	0.00063	CcSEcCtD
Travoprost—Dermatitis—Erlotinib—kidney cancer	0.000612	0.000629	CcSEcCtD
Travoprost—Palpitations—Paclitaxel—kidney cancer	0.000611	0.000629	CcSEcCtD
Travoprost—Eye disorder—Capecitabine—kidney cancer	0.00061	0.000627	CcSEcCtD
Travoprost—Headache—Erlotinib—kidney cancer	0.000608	0.000626	CcSEcCtD
Travoprost—Tinnitus—Capecitabine—kidney cancer	0.000608	0.000626	CcSEcCtD
Travoprost—Constipation—Vincristine—kidney cancer	0.000608	0.000625	CcSEcCtD
Travoprost—Pain—Vincristine—kidney cancer	0.000608	0.000625	CcSEcCtD
Travoprost—Cardiac disorder—Capecitabine—kidney cancer	0.000605	0.000623	CcSEcCtD
Travoprost—Cough—Paclitaxel—kidney cancer	0.000604	0.000621	CcSEcCtD
Travoprost—Asthenia—Sunitinib—kidney cancer	0.000603	0.00062	CcSEcCtD
Travoprost—Dyspnoea—Gemcitabine—kidney cancer	0.000601	0.000619	CcSEcCtD
Travoprost—Nausea—Vinblastine—kidney cancer	0.0006	0.000617	CcSEcCtD
Travoprost—Nausea—Everolimus—kidney cancer	0.000598	0.000615	CcSEcCtD
Travoprost—Diarrhoea—Sorafenib—kidney cancer	0.000598	0.000615	CcSEcCtD
Travoprost—Hypertension—Paclitaxel—kidney cancer	0.000597	0.000614	CcSEcCtD
Travoprost—Pruritus—Sunitinib—kidney cancer	0.000595	0.000612	CcSEcCtD
Travoprost—Angiopathy—Capecitabine—kidney cancer	0.000592	0.000609	CcSEcCtD
Travoprost—Immune system disorder—Capecitabine—kidney cancer	0.000589	0.000606	CcSEcCtD
Travoprost—Myalgia—Paclitaxel—kidney cancer	0.000589	0.000606	CcSEcCtD
Travoprost—Chest pain—Paclitaxel—kidney cancer	0.000589	0.000606	CcSEcCtD
Travoprost—Arthralgia—Paclitaxel—kidney cancer	0.000589	0.000606	CcSEcCtD
Travoprost—Mediastinal disorder—Capecitabine—kidney cancer	0.000588	0.000605	CcSEcCtD
Travoprost—Anxiety—Paclitaxel—kidney cancer	0.000587	0.000604	CcSEcCtD
Travoprost—Hypersensitivity—Dactinomycin—kidney cancer	0.000586	0.000603	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000585	0.000602	CcSEcCtD
Travoprost—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000582	0.000599	CcSEcCtD
Travoprost—Discomfort—Paclitaxel—kidney cancer	0.000582	0.000599	CcSEcCtD
Travoprost—Fatigue—Gemcitabine—kidney cancer	0.000582	0.000598	CcSEcCtD
Travoprost—Gastrointestinal pain—Vincristine—kidney cancer	0.000581	0.000598	CcSEcCtD
Travoprost—Dizziness—Sorafenib—kidney cancer	0.000578	0.000594	CcSEcCtD
Travoprost—Pain—Gemcitabine—kidney cancer	0.000577	0.000593	CcSEcCtD
Travoprost—Constipation—Gemcitabine—kidney cancer	0.000577	0.000593	CcSEcCtD
Travoprost—Nausea—Erlotinib—kidney cancer	0.000577	0.000593	CcSEcCtD
Travoprost—Dry mouth—Paclitaxel—kidney cancer	0.000576	0.000593	CcSEcCtD
Travoprost—Diarrhoea—Sunitinib—kidney cancer	0.000575	0.000592	CcSEcCtD
Travoprost—Mental disorder—Capecitabine—kidney cancer	0.000571	0.000588	CcSEcCtD
Travoprost—Asthenia—Dactinomycin—kidney cancer	0.000571	0.000587	CcSEcCtD
Travoprost—Erythema—Capecitabine—kidney cancer	0.000568	0.000584	CcSEcCtD
Travoprost—Oedema—Paclitaxel—kidney cancer	0.000565	0.000581	CcSEcCtD
Travoprost—Abdominal pain—Vincristine—kidney cancer	0.000562	0.000578	CcSEcCtD
Travoprost—Infection—Paclitaxel—kidney cancer	0.000561	0.000577	CcSEcCtD
Travoprost—Dysgeusia—Capecitabine—kidney cancer	0.000556	0.000572	CcSEcCtD
Travoprost—Dizziness—Sunitinib—kidney cancer	0.000556	0.000572	CcSEcCtD
Travoprost—Feeling abnormal—Gemcitabine—kidney cancer	0.000556	0.000572	CcSEcCtD
Travoprost—Nervous system disorder—Paclitaxel—kidney cancer	0.000554	0.00057	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000553	0.0209	CbGpPWpGaD
Travoprost—Tachycardia—Paclitaxel—kidney cancer	0.000551	0.000567	CcSEcCtD
Travoprost—Rash—Sorafenib—kidney cancer	0.000551	0.000567	CcSEcCtD
Travoprost—Dermatitis—Sorafenib—kidney cancer	0.00055	0.000566	CcSEcCtD
Travoprost—Back pain—Capecitabine—kidney cancer	0.000549	0.000565	CcSEcCtD
Travoprost—Skin disorder—Paclitaxel—kidney cancer	0.000549	0.000564	CcSEcCtD
Travoprost—Headache—Sorafenib—kidney cancer	0.000547	0.000563	CcSEcCtD
Travoprost—Diarrhoea—Dactinomycin—kidney cancer	0.000544	0.00056	CcSEcCtD
Travoprost—Vision blurred—Capecitabine—kidney cancer	0.000535	0.00055	CcSEcCtD
Travoprost—Rash—Sunitinib—kidney cancer	0.00053	0.000545	CcSEcCtD
Travoprost—Dermatitis—Sunitinib—kidney cancer	0.00053	0.000545	CcSEcCtD
Travoprost—Hypotension—Paclitaxel—kidney cancer	0.000528	0.000543	CcSEcCtD
Travoprost—Ill-defined disorder—Capecitabine—kidney cancer	0.000527	0.000542	CcSEcCtD
Travoprost—Headache—Sunitinib—kidney cancer	0.000527	0.000542	CcSEcCtD
Travoprost—Influenza—Doxorubicin—kidney cancer	0.000525	0.00054	CcSEcCtD
Travoprost—Asthma—Doxorubicin—kidney cancer	0.000525	0.00054	CcSEcCtD
Travoprost—Hypersensitivity—Vincristine—kidney cancer	0.000524	0.000539	CcSEcCtD
Travoprost—Nausea—Sorafenib—kidney cancer	0.000519	0.000534	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—ANXA1—kidney cancer	0.000518	0.0196	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000515	0.000529	CcSEcCtD
Travoprost—Malaise—Capecitabine—kidney cancer	0.000512	0.000527	CcSEcCtD
Travoprost—Angina pectoris—Doxorubicin—kidney cancer	0.000512	0.000526	CcSEcCtD
Travoprost—Vertigo—Capecitabine—kidney cancer	0.00051	0.000525	CcSEcCtD
Travoprost—Asthenia—Vincristine—kidney cancer	0.00051	0.000525	CcSEcCtD
Travoprost—Bronchitis—Doxorubicin—kidney cancer	0.000505	0.00052	CcSEcCtD
Travoprost—Dyspnoea—Paclitaxel—kidney cancer	0.000503	0.000518	CcSEcCtD
Travoprost—Palpitations—Capecitabine—kidney cancer	0.000502	0.000516	CcSEcCtD
Travoprost—Rash—Dactinomycin—kidney cancer	0.000502	0.000516	CcSEcCtD
Travoprost—Nausea—Sunitinib—kidney cancer	0.000499	0.000514	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—OR4C13—kidney cancer	0.000499	0.0189	CbGpPWpGaD
Travoprost—Dyspepsia—Paclitaxel—kidney cancer	0.000497	0.000511	CcSEcCtD
Travoprost—Cough—Capecitabine—kidney cancer	0.000496	0.00051	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—kidney cancer	0.000491	0.000505	CcSEcCtD
Travoprost—Hypertension—Capecitabine—kidney cancer	0.00049	0.000504	CcSEcCtD
Travoprost—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000488	0.000501	CcSEcCtD
Travoprost—Fatigue—Paclitaxel—kidney cancer	0.000487	0.000501	CcSEcCtD
Travoprost—Diarrhoea—Vincristine—kidney cancer	0.000486	0.0005	CcSEcCtD
Travoprost—Asthenia—Gemcitabine—kidney cancer	0.000484	0.000498	CcSEcCtD
Travoprost—Arthralgia—Capecitabine—kidney cancer	0.000483	0.000497	CcSEcCtD
Travoprost—Myalgia—Capecitabine—kidney cancer	0.000483	0.000497	CcSEcCtD
Travoprost—Chest pain—Capecitabine—kidney cancer	0.000483	0.000497	CcSEcCtD
Travoprost—Pain—Paclitaxel—kidney cancer	0.000483	0.000497	CcSEcCtD
Travoprost—Constipation—Paclitaxel—kidney cancer	0.000483	0.000497	CcSEcCtD
Travoprost—Anxiety—Capecitabine—kidney cancer	0.000482	0.000496	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00048	0.000494	CcSEcCtD
Travoprost—Discomfort—Capecitabine—kidney cancer	0.000478	0.000491	CcSEcCtD
Travoprost—Pruritus—Gemcitabine—kidney cancer	0.000477	0.000491	CcSEcCtD
Travoprost—Dry mouth—Capecitabine—kidney cancer	0.000473	0.000486	CcSEcCtD
Travoprost—Nausea—Dactinomycin—kidney cancer	0.000473	0.000486	CcSEcCtD
Travoprost—Dizziness—Vincristine—kidney cancer	0.00047	0.000484	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—kidney cancer	0.000468	0.000482	CcSEcCtD
Travoprost—Infestation—Doxorubicin—kidney cancer	0.000468	0.000482	CcSEcCtD
Travoprost—Feeling abnormal—Paclitaxel—kidney cancer	0.000465	0.000479	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000464	0.0175	CbGpPWpGaD
Travoprost—Oedema—Capecitabine—kidney cancer	0.000463	0.000477	CcSEcCtD
Travoprost—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000462	0.000475	CcSEcCtD
Travoprost—Diarrhoea—Gemcitabine—kidney cancer	0.000461	0.000475	CcSEcCtD
Travoprost—Infection—Capecitabine—kidney cancer	0.00046	0.000474	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—kidney cancer	0.000455	0.000468	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—kidney cancer	0.000455	0.000468	CcSEcCtD
Travoprost—Nervous system disorder—Capecitabine—kidney cancer	0.000454	0.000467	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—OR4C13—kidney cancer	0.000453	0.0171	CbGpPWpGaD
Travoprost—Tachycardia—Capecitabine—kidney cancer	0.000452	0.000465	CcSEcCtD
Travoprost—Skin disorder—Capecitabine—kidney cancer	0.00045	0.000463	CcSEcCtD
Travoprost—Rash—Vincristine—kidney cancer	0.000448	0.000461	CcSEcCtD
Travoprost—Dermatitis—Vincristine—kidney cancer	0.000448	0.000461	CcSEcCtD
Travoprost—Abdominal pain—Paclitaxel—kidney cancer	0.000446	0.000459	CcSEcCtD
Travoprost—Headache—Vincristine—kidney cancer	0.000445	0.000458	CcSEcCtD
Travoprost—Sinusitis—Doxorubicin—kidney cancer	0.000439	0.000452	CcSEcCtD
Travoprost—Hypotension—Capecitabine—kidney cancer	0.000433	0.000445	CcSEcCtD
Travoprost—Bradycardia—Doxorubicin—kidney cancer	0.000428	0.00044	CcSEcCtD
Travoprost—Rash—Gemcitabine—kidney cancer	0.000425	0.000437	CcSEcCtD
Travoprost—Dermatitis—Gemcitabine—kidney cancer	0.000425	0.000437	CcSEcCtD
Travoprost—Headache—Gemcitabine—kidney cancer	0.000423	0.000435	CcSEcCtD
Travoprost—Nausea—Vincristine—kidney cancer	0.000422	0.000434	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000422	0.000434	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—kidney cancer	0.000422	0.000434	CcSEcCtD
Travoprost—Pharyngitis—Doxorubicin—kidney cancer	0.000417	0.000429	CcSEcCtD
Travoprost—Hypersensitivity—Paclitaxel—kidney cancer	0.000416	0.000428	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—kidney cancer	0.000415	0.000427	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—kidney cancer	0.000413	0.000425	CcSEcCtD
Travoprost—Dyspnoea—Capecitabine—kidney cancer	0.000413	0.000425	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—kidney cancer	0.000412	0.000424	CcSEcCtD
Travoprost—Dyspepsia—Capecitabine—kidney cancer	0.000408	0.00042	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—kidney cancer	0.000405	0.000417	CcSEcCtD
Travoprost—Asthenia—Paclitaxel—kidney cancer	0.000405	0.000417	CcSEcCtD
Travoprost—Nausea—Gemcitabine—kidney cancer	0.000401	0.000412	CcSEcCtD
Travoprost—Gastrointestinal disorder—Capecitabine—kidney cancer	0.0004	0.000412	CcSEcCtD
Travoprost—Fatigue—Capecitabine—kidney cancer	0.0004	0.000411	CcSEcCtD
Travoprost—Pruritus—Paclitaxel—kidney cancer	0.0004	0.000411	CcSEcCtD
Travoprost—Constipation—Capecitabine—kidney cancer	0.000396	0.000408	CcSEcCtD
Travoprost—Pain—Capecitabine—kidney cancer	0.000396	0.000408	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—kidney cancer	0.000393	0.000404	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—kidney cancer	0.000392	0.000403	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—kidney cancer	0.00039	0.000401	CcSEcCtD
Travoprost—Diarrhoea—Paclitaxel—kidney cancer	0.000386	0.000397	CcSEcCtD
Travoprost—Feeling abnormal—Capecitabine—kidney cancer	0.000382	0.000393	CcSEcCtD
Travoprost—Angiopathy—Doxorubicin—kidney cancer	0.000381	0.000392	CcSEcCtD
Travoprost—Immune system disorder—Doxorubicin—kidney cancer	0.00038	0.000391	CcSEcCtD
Travoprost—Gastrointestinal pain—Capecitabine—kidney cancer	0.000379	0.00039	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—kidney cancer	0.000379	0.00039	CcSEcCtD
Travoprost—Dizziness—Paclitaxel—kidney cancer	0.000373	0.000384	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—kidney cancer	0.000368	0.000379	CcSEcCtD
Travoprost—Abdominal pain—Capecitabine—kidney cancer	0.000366	0.000377	CcSEcCtD
Travoprost—Erythema—Doxorubicin—kidney cancer	0.000366	0.000376	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—kidney cancer	0.000358	0.000369	CcSEcCtD
Travoprost—Rash—Paclitaxel—kidney cancer	0.000356	0.000366	CcSEcCtD
Travoprost—Dermatitis—Paclitaxel—kidney cancer	0.000356	0.000366	CcSEcCtD
Travoprost—Back pain—Doxorubicin—kidney cancer	0.000354	0.000364	CcSEcCtD
Travoprost—Headache—Paclitaxel—kidney cancer	0.000354	0.000364	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—kidney cancer	0.000345	0.000355	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000343	0.013	CbGpPWpGaD
Travoprost—Hypersensitivity—Capecitabine—kidney cancer	0.000341	0.000351	CcSEcCtD
Travoprost—Ill-defined disorder—Doxorubicin—kidney cancer	0.00034	0.000349	CcSEcCtD
Travoprost—Nausea—Paclitaxel—kidney cancer	0.000335	0.000345	CcSEcCtD
Travoprost—Asthenia—Capecitabine—kidney cancer	0.000333	0.000342	CcSEcCtD
Travoprost—Malaise—Doxorubicin—kidney cancer	0.00033	0.00034	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—kidney cancer	0.000329	0.000338	CcSEcCtD
Travoprost—Pruritus—Capecitabine—kidney cancer	0.000328	0.000337	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—kidney cancer	0.000323	0.000333	CcSEcCtD
Travoprost—Cough—Doxorubicin—kidney cancer	0.000319	0.000329	CcSEcCtD
Travoprost—Diarrhoea—Capecitabine—kidney cancer	0.000317	0.000326	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—kidney cancer	0.000316	0.000325	CcSEcCtD
Travoprost—Myalgia—Doxorubicin—kidney cancer	0.000312	0.000321	CcSEcCtD
Travoprost—Chest pain—Doxorubicin—kidney cancer	0.000312	0.000321	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—kidney cancer	0.000312	0.000321	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—kidney cancer	0.000311	0.000319	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000309	0.000318	CcSEcCtD
Travoprost—Discomfort—Doxorubicin—kidney cancer	0.000308	0.000317	CcSEcCtD
Travoprost—Dizziness—Capecitabine—kidney cancer	0.000306	0.000315	CcSEcCtD
Travoprost—Dry mouth—Doxorubicin—kidney cancer	0.000305	0.000313	CcSEcCtD
Travoprost—Oedema—Doxorubicin—kidney cancer	0.000299	0.000307	CcSEcCtD
Travoprost—Infection—Doxorubicin—kidney cancer	0.000297	0.000305	CcSEcCtD
Travoprost—Nervous system disorder—Doxorubicin—kidney cancer	0.000293	0.000301	CcSEcCtD
Travoprost—Rash—Capecitabine—kidney cancer	0.000292	0.000301	CcSEcCtD
Travoprost—Dermatitis—Capecitabine—kidney cancer	0.000292	0.0003	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—kidney cancer	0.000292	0.0003	CcSEcCtD
Travoprost—Headache—Capecitabine—kidney cancer	0.00029	0.000299	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—kidney cancer	0.00029	0.000298	CcSEcCtD
Travoprost—Hypotension—Doxorubicin—kidney cancer	0.000279	0.000287	CcSEcCtD
Travoprost—Nausea—Capecitabine—kidney cancer	0.000275	0.000283	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000272	0.00028	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—OR4C13—kidney cancer	0.000268	0.0101	CbGpPWpGaD
Travoprost—Dyspnoea—Doxorubicin—kidney cancer	0.000266	0.000274	CcSEcCtD
Travoprost—Dyspepsia—Doxorubicin—kidney cancer	0.000263	0.00027	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ANXA1—kidney cancer	0.000261	0.00988	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000258	0.000265	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—kidney cancer	0.000258	0.000265	CcSEcCtD
Travoprost—Pain—Doxorubicin—kidney cancer	0.000255	0.000263	CcSEcCtD
Travoprost—Constipation—Doxorubicin—kidney cancer	0.000255	0.000263	CcSEcCtD
Travoprost—Feeling abnormal—Doxorubicin—kidney cancer	0.000246	0.000253	CcSEcCtD
Travoprost—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000244	0.000251	CcSEcCtD
Travoprost—Abdominal pain—Doxorubicin—kidney cancer	0.000236	0.000243	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—LATS1—kidney cancer	0.000228	0.00861	CbGpPWpGaD
Travoprost—Hypersensitivity—Doxorubicin—kidney cancer	0.00022	0.000226	CcSEcCtD
Travoprost—Asthenia—Doxorubicin—kidney cancer	0.000214	0.00022	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—kidney cancer	0.000211	0.000217	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AKAP13—kidney cancer	0.000207	0.00784	CbGpPWpGaD
Travoprost—Diarrhoea—Doxorubicin—kidney cancer	0.000204	0.00021	CcSEcCtD
Travoprost—Dizziness—Doxorubicin—kidney cancer	0.000198	0.000203	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AMER1—kidney cancer	0.000194	0.00732	CbGpPWpGaD
Travoprost—Rash—Doxorubicin—kidney cancer	0.000188	0.000194	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AKAP13—kidney cancer	0.000188	0.00712	CbGpPWpGaD
Travoprost—Dermatitis—Doxorubicin—kidney cancer	0.000188	0.000194	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000187	0.00708	CbGpPWpGaD
Travoprost—Headache—Doxorubicin—kidney cancer	0.000187	0.000192	CcSEcCtD
Travoprost—Nausea—Doxorubicin—kidney cancer	0.000177	0.000183	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ITPR2—kidney cancer	0.000176	0.00666	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000168	0.00636	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CER1—kidney cancer	0.000162	0.00613	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GPC3—kidney cancer	0.000162	0.00613	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ITPR2—kidney cancer	0.00016	0.00605	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ANXA1—kidney cancer	0.000148	0.00558	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SFRP2—kidney cancer	0.000138	0.00522	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000135	0.0051	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ANXA1—kidney cancer	0.000134	0.00507	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000128	0.00486	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—POMC—kidney cancer	0.000128	0.00484	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000125	0.00471	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000121	0.00459	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000111	0.00421	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKAP13—kidney cancer	0.000111	0.0042	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASP2—kidney cancer	0.000111	0.0042	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRB7—kidney cancer	0.000102	0.00385	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ITPR2—kidney cancer	9.45e-05	0.00358	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CTNNA1—kidney cancer	8.57e-05	0.00324	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—EIF4EBP1—kidney cancer	8.52e-05	0.00322	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HSPB1—kidney cancer	8.52e-05	0.00322	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PSMD7—kidney cancer	7.92e-05	0.003	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TSC1—kidney cancer	7.92e-05	0.003	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ANXA1—kidney cancer	7.92e-05	0.003	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FLT1—kidney cancer	7.67e-05	0.0029	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—POMC—kidney cancer	7.24e-05	0.00274	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUNB—kidney cancer	7.11e-05	0.00269	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PAK1—kidney cancer	7.11e-05	0.00269	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—POMC—kidney cancer	6.57e-05	0.00248	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF2—kidney cancer	5.82e-05	0.0022	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDKN2B—kidney cancer	5.79e-05	0.00219	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF1R—kidney cancer	5.62e-05	0.00213	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—RAF1—kidney cancer	5.42e-05	0.00205	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—IL2—kidney cancer	5.35e-05	0.00202	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL2—kidney cancer	4.86e-05	0.00184	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HIF1A—kidney cancer	4.63e-05	0.00175	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TSC2—kidney cancer	4.62e-05	0.00175	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KDR—kidney cancer	4.43e-05	0.00167	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KIT—kidney cancer	4.08e-05	0.00154	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APC—kidney cancer	4.08e-05	0.00154	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK3—kidney cancer	3.91e-05	0.00148	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—POMC—kidney cancer	3.88e-05	0.00147	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BRAF—kidney cancer	3.83e-05	0.00145	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MAPK1—kidney cancer	3.72e-05	0.00141	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CA—kidney cancer	3.55e-05	0.00134	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—KRAS—kidney cancer	3.51e-05	0.00133	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CA—kidney cancer	3.22e-05	0.00122	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RAF1—kidney cancer	3.2e-05	0.00121	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RELA—kidney cancer	3.19e-05	0.0012	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ERBB2—kidney cancer	3.17e-05	0.0012	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MTOR—kidney cancer	3.12e-05	0.00118	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDKN1B—kidney cancer	2.93e-05	0.00111	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL2—kidney cancer	2.87e-05	0.00109	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCND1—kidney cancer	2.8e-05	0.00106	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUN—kidney cancer	2.79e-05	0.00106	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CTNNB1—kidney cancer	2.77e-05	0.00105	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTEN—kidney cancer	2.7e-05	0.00102	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—kidney cancer	2.44e-05	0.000922	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK3—kidney cancer	2.31e-05	0.000872	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MYC—kidney cancer	2.24e-05	0.000848	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK1—kidney cancer	2.2e-05	0.00083	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KRAS—kidney cancer	2.07e-05	0.000784	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CA—kidney cancer	1.9e-05	0.00072	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TP53—kidney cancer	1.84e-05	0.000697	CbGpPWpGaD
